Japan Celecoxib Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Celecoxib market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Celecoxib market. Detailed analysis of key players, along with key growth strategies adopted by Celecoxib industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Shire

    • Anhui Heyi Chemical

    • Pfizer

    • Jiangsu Chiatai Qingjiang Pharmaceutical

    • Mylan

    • Chengdu Suncadia Pharmaceuticals

    • Teva

    By Type:

    • 50mg Celecoxib

    • 100mg Celecoxib

    • 200mg Celecoxib

    • 400mg Celecoxib

    By End-User:

    • Rheumatoid Arthritis

    • Osteoarthritis

    • Acute Pain

    • Musculoskeletal Pain

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Celecoxib Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Celecoxib Market Size and Growth Rate of 50mg Celecoxib from 2014 to 2026

      • 1.3.2 Japan Celecoxib Market Size and Growth Rate of 100mg Celecoxib from 2014 to 2026

      • 1.3.3 Japan Celecoxib Market Size and Growth Rate of 200mg Celecoxib from 2014 to 2026

      • 1.3.4 Japan Celecoxib Market Size and Growth Rate of 400mg Celecoxib from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Rheumatoid Arthritis

      • 1.4.2 Market Size and Growth Rate of Osteoarthritis

      • 1.4.3 Market Size and Growth Rate of Acute Pain

      • 1.4.4 Market Size and Growth Rate of Musculoskeletal Pain

      • 1.4.5 Market Size and Growth Rate of Others

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Celecoxib Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Celecoxib by Major Types

      • 3.4.1 Japan Celecoxib Market Size and Growth Rate of 50mg Celecoxib from 2014 to 2026

      • 3.4.2 Japan Celecoxib Market Size and Growth Rate of 100mg Celecoxib from 2014 to 2026

      • 3.4.3 Japan Celecoxib Market Size and Growth Rate of 200mg Celecoxib from 2014 to 2026

      • 3.4.4 Japan Celecoxib Market Size and Growth Rate of 400mg Celecoxib from 2014 to 2026

    4 Segmentation of Celecoxib Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Celecoxib by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Celecoxib in Rheumatoid Arthritis

      • 4.4.2 Market Size and Growth Rate of Celecoxib in Osteoarthritis

      • 4.4.3 Market Size and Growth Rate of Celecoxib in Acute Pain

      • 4.4.4 Market Size and Growth Rate of Celecoxib in Musculoskeletal Pain

      • 4.4.5 Market Size and Growth Rate of Celecoxib in Others

    5 Market Analysis by Regions

    • 5.1 Japan Celecoxib Production Analysis by Regions

    • 5.2 Japan Celecoxib Consumption Analysis by Regions

    6 Hokkaido Celecoxib Landscape Analysis

    • 6.1 Hokkaido Celecoxib Landscape Analysis by Major Types

    • 6.2 Hokkaido Celecoxib Landscape Analysis by Major End-Users

    7 Tohoku Celecoxib Landscape Analysis

    • 7.1 Tohoku Celecoxib Landscape Analysis by Major Types

    • 7.2 Tohoku Celecoxib Landscape Analysis by Major End-Users

    8 Kanto Celecoxib Landscape Analysis

    • 8.1 Kanto Celecoxib Landscape Analysis by Major Types

    • 8.2 Kanto Celecoxib Landscape Analysis by Major End-Users

    9 Chubu Celecoxib Landscape Analysis

    • 9.1 Chubu Celecoxib Landscape Analysis by Major Types

    • 9.2 Chubu Celecoxib Landscape Analysis by Major End-Users

    10 Kinki Celecoxib Landscape Analysis

    • 10.1 Kinki Celecoxib Landscape Analysis by Major Types

    • 10.2 Kinki Celecoxib Landscape Analysis by Major End-Users

    11 Chugoku Celecoxib Landscape Analysis

    • 11.1 Chugoku Celecoxib Landscape Analysis by Major Types

    • 11.2 Chugoku Celecoxib Landscape Analysis by Major End-Users

    12 Shikoku Celecoxib Landscape Analysis

    • 12.1 Shikoku Celecoxib Landscape Analysis by Major Types

    • 12.2 Shikoku Celecoxib Landscape Analysis by Major End-Users

    13 Kyushu Celecoxib Landscape Analysis

    • 13.1 Kyushu Celecoxib Landscape Analysis by Major Types

    • 13.2 Kyushu Celecoxib Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Shire

      • 14.1.1 Shire Company Profile and Recent Development

      • 14.1.2 Shire Market Performance

      • 14.1.3 Shire Product and Service Introduction

    • 14.2 Anhui Heyi Chemical

      • 14.2.1 Anhui Heyi Chemical Company Profile and Recent Development

      • 14.2.2 Anhui Heyi Chemical Market Performance

      • 14.2.3 Anhui Heyi Chemical Product and Service Introduction

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Profile and Recent Development

      • 14.3.2 Pfizer Market Performance

      • 14.3.3 Pfizer Product and Service Introduction

    • 14.4 Jiangsu Chiatai Qingjiang Pharmaceutical

      • 14.4.1 Jiangsu Chiatai Qingjiang Pharmaceutical Company Profile and Recent Development

      • 14.4.2 Jiangsu Chiatai Qingjiang Pharmaceutical Market Performance

      • 14.4.3 Jiangsu Chiatai Qingjiang Pharmaceutical Product and Service Introduction

    • 14.5 Mylan

      • 14.5.1 Mylan Company Profile and Recent Development

      • 14.5.2 Mylan Market Performance

      • 14.5.3 Mylan Product and Service Introduction

    • 14.6 Chengdu Suncadia Pharmaceuticals

      • 14.6.1 Chengdu Suncadia Pharmaceuticals Company Profile and Recent Development

      • 14.6.2 Chengdu Suncadia Pharmaceuticals Market Performance

      • 14.6.3 Chengdu Suncadia Pharmaceuticals Product and Service Introduction

    • 14.7 Teva

      • 14.7.1 Teva Company Profile and Recent Development

      • 14.7.2 Teva Market Performance

      • 14.7.3 Teva Product and Service Introduction

     

    The List of Tables and Figures (Totals 108 Figures and 185 Tables)

    • Figure Japan Celecoxib Market Size and Growth Rate of 50mg Celecoxib from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 100mg Celecoxib from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 200mg Celecoxib from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 400mg Celecoxib from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Rheumatoid Arthritis

    • Figure Market Size and Growth Rate of Osteoarthritis

    • Figure Market Size and Growth Rate of Acute Pain

    • Figure Market Size and Growth Rate of Musculoskeletal Pain

    • Figure Market Size and Growth Rate of Others

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Celecoxib Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Celecoxib Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Celecoxib

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Celecoxib by Different Types from 2014 to 2026

    • Table Consumption Share of Celecoxib by Different Types from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 50mg Celecoxib from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 100mg Celecoxib from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 200mg Celecoxib from 2014 to 2026

    • Figure Japan Celecoxib Market Size and Growth Rate of 400mg Celecoxib from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Celecoxib by Different End-Users from 2014 to 2026

    • Table Consumption Share of Celecoxib by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Rheumatoid Arthritis

    • Figure Market Size and Growth Rate of Osteoarthritis

    • Figure Market Size and Growth Rate of Acute Pain

    • Figure Market Size and Growth Rate of Musculoskeletal Pain

    • Figure Market Size and Growth Rate of Others

    • Table Japan Celecoxib Production by Regions

    • Table Japan Celecoxib Production Share by Regions

    • Figure Japan Celecoxib Production Share by Regions in 2014

    • Figure Japan Celecoxib Production Share by Regions in 2018

    • Figure Japan Celecoxib Production Share by Regions in 2026

    • Table Japan Celecoxib Consumption by Regions

    • Table Japan Celecoxib Consumption Share by Regions

    • Figure Japan Celecoxib Consumption Share by Regions in 2014

    • Figure Japan Celecoxib Consumption Share by Regions in 2018

    • Figure Japan Celecoxib Consumption Share by Regions in 2026

    • Table Hokkaido Celecoxib Consumption by Types from 2014 to 2026

    • Table Hokkaido Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Celecoxib Consumption Share by Types in 2014

    • Figure Hokkaido Celecoxib Consumption Share by Types in 2018

    • Figure Hokkaido Celecoxib Consumption Share by Types in 2026

    • Table Hokkaido Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Celecoxib Consumption Share by End-Users in 2014

    • Figure Hokkaido Celecoxib Consumption Share by End-Users in 2018

    • Figure Hokkaido Celecoxib Consumption Share by End-Users in 2026

    • Table Tohoku Celecoxib Consumption by Types from 2014 to 2026

    • Table Tohoku Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Celecoxib Consumption Share by Types in 2014

    • Figure Tohoku Celecoxib Consumption Share by Types in 2018

    • Figure Tohoku Celecoxib Consumption Share by Types in 2026

    • Table Tohoku Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Tohoku Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Celecoxib Consumption Share by End-Users in 2014

    • Figure Tohoku Celecoxib Consumption Share by End-Users in 2018

    • Figure Tohoku Celecoxib Consumption Share by End-Users in 2026

    • Table Kanto Celecoxib Consumption by Types from 2014 to 2026

    • Table Kanto Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Kanto Celecoxib Consumption Share by Types in 2014

    • Figure Kanto Celecoxib Consumption Share by Types in 2018

    • Figure Kanto Celecoxib Consumption Share by Types in 2026

    • Table Kanto Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Kanto Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Celecoxib Consumption Share by End-Users in 2014

    • Figure Kanto Celecoxib Consumption Share by End-Users in 2018

    • Figure Kanto Celecoxib Consumption Share by End-Users in 2026

    • Table Chubu Celecoxib Consumption by Types from 2014 to 2026

    • Table Chubu Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Chubu Celecoxib Consumption Share by Types in 2014

    • Figure Chubu Celecoxib Consumption Share by Types in 2018

    • Figure Chubu Celecoxib Consumption Share by Types in 2026

    • Table Chubu Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Chubu Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Celecoxib Consumption Share by End-Users in 2014

    • Figure Chubu Celecoxib Consumption Share by End-Users in 2018

    • Figure Chubu Celecoxib Consumption Share by End-Users in 2026

    • Table Kinki Celecoxib Consumption by Types from 2014 to 2026

    • Table Kinki Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Kinki Celecoxib Consumption Share by Types in 2014

    • Figure Kinki Celecoxib Consumption Share by Types in 2018

    • Figure Kinki Celecoxib Consumption Share by Types in 2026

    • Table Kinki Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Kinki Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Celecoxib Consumption Share by End-Users in 2014

    • Figure Kinki Celecoxib Consumption Share by End-Users in 2018

    • Figure Kinki Celecoxib Consumption Share by End-Users in 2026

    • Table Chugoku Celecoxib Consumption by Types from 2014 to 2026

    • Table Chugoku Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Celecoxib Consumption Share by Types in 2014

    • Figure Chugoku Celecoxib Consumption Share by Types in 2018

    • Figure Chugoku Celecoxib Consumption Share by Types in 2026

    • Table Chugoku Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Chugoku Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Celecoxib Consumption Share by End-Users in 2014

    • Figure Chugoku Celecoxib Consumption Share by End-Users in 2018

    • Figure Chugoku Celecoxib Consumption Share by End-Users in 2026

    • Table Shikoku Celecoxib Consumption by Types from 2014 to 2026

    • Table Shikoku Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Celecoxib Consumption Share by Types in 2014

    • Figure Shikoku Celecoxib Consumption Share by Types in 2018

    • Figure Shikoku Celecoxib Consumption Share by Types in 2026

    • Table Shikoku Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Shikoku Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Celecoxib Consumption Share by End-Users in 2014

    • Figure Shikoku Celecoxib Consumption Share by End-Users in 2018

    • Figure Shikoku Celecoxib Consumption Share by End-Users in 2026

    • Table Kyushu Celecoxib Consumption by Types from 2014 to 2026

    • Table Kyushu Celecoxib Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Celecoxib Consumption Share by Types in 2014

    • Figure Kyushu Celecoxib Consumption Share by Types in 2018

    • Figure Kyushu Celecoxib Consumption Share by Types in 2026

    • Table Kyushu Celecoxib Consumption by End-Users from 2014 to 2026

    • Table Kyushu Celecoxib Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Celecoxib Consumption Share by End-Users in 2014

    • Figure Kyushu Celecoxib Consumption Share by End-Users in 2018

    • Figure Kyushu Celecoxib Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Shire

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

    • Figure Sales and Growth Rate Analysis of Shire

    • Figure Revenue and Market Share Analysis of Shire

    • Table Product and Service Introduction of Shire

    • Table Company Profile and Development Status of Anhui Heyi Chemical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anhui Heyi Chemical

    • Figure Sales and Growth Rate Analysis of Anhui Heyi Chemical

    • Figure Revenue and Market Share Analysis of Anhui Heyi Chemical

    • Table Product and Service Introduction of Anhui Heyi Chemical

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Jiangsu Chiatai Qingjiang Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Chiatai Qingjiang Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Jiangsu Chiatai Qingjiang Pharmaceutical

    • Figure Revenue and Market Share Analysis of Jiangsu Chiatai Qingjiang Pharmaceutical

    • Table Product and Service Introduction of Jiangsu Chiatai Qingjiang Pharmaceutical

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Chengdu Suncadia Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chengdu Suncadia Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Chengdu Suncadia Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Chengdu Suncadia Pharmaceuticals

    • Table Product and Service Introduction of Chengdu Suncadia Pharmaceuticals

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.